Synthetic Vaccines
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 21 June 2024 | Viewed by 193
Special Issue Editor
Special Issue Information
Dear Colleagues,
Synthetic vaccines are immunization systems comprised of biomolecular sub-units (i.e., nucleic acids, proteins, carbohydrates, and/or lipids) capable of replicating the immunogenic aspects of pathogens without the inclusion of deleterious components. The move away from whole-killed and attenuated vaccine approaches towards synthetic vaccines has been in progress for the past couple of decades, culminating in the use of nucleic acid-based vaccines to protect against SARS-CoV-2. Reaching this pivot point, the vaccination community is now ready to expedite the research and commercialization of a wide variety of synthetic vaccines to protect against a wide swath of pathogenic agents. This Special Issue focuses on highlighting the excellent work being conducted in this community by emerging and established researchers.
Dr. Bret D. Ulery
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- biomolecules
- biomaterials
- drug delivery
- immunology
